id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-1665-0007,FDA,FDA-2015-E-1665,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2019-03-07T05:00:00Z,2019,3,2019-03-07T05:00:00Z,,2019-03-07T16:45:36Z,,0,0,0900006483aca781
FDA-2015-E-1665-0006,FDA,FDA-2015-E-1665,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ZONTIVITY",Notice,Determinations,2018-02-15T05:00:00Z,2018,2,2018-02-15T05:00:00Z,2018-04-17T03:59:59Z,2018-02-15T15:38:38Z,2018-03170,0,0,0900006482f338bd
FDA-2015-E-1665-0005,FDA,FDA-2015-E-1665,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-06T04:00:00Z,2017,6,2017-06-06T04:00:00Z,,2017-06-06T14:20:25Z,,0,0,09000064826971fa
FDA-2015-E-1665-0004,FDA,FDA-2015-E-1665,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T18:01:04Z,,0,0,09000064824344c8
FDA-2015-E-1665-0003,FDA,FDA-2015-E-1665,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-05T05:00:00Z,2015,11,2015-11-05T05:00:00Z,,2015-11-05T14:53:25Z,,0,0,0900006481d1489f
FDA-2015-E-1665-0002,FDA,FDA-2015-E-1665,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-05-12T04:00:00Z,2015,5,2015-05-12T04:00:00Z,,2015-05-12T13:29:07Z,,0,0,0900006481ada5ef
FDA-2015-E-1665-0001,FDA,FDA-2015-E-1665,Patent Extension Application from MERCK SHARP & DOHME CORP.,Other,Application,2015-05-12T04:00:00Z,2015,5,2015-05-12T04:00:00Z,,2015-05-12T13:29:01Z,,0,0,0900006481ada5f1